Home/Filings/4/0001567619-22-011218
4//SEC Filing

Burkhart Erin 4

Accession 0001567619-22-011218

CIK 0001048477other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 8:42 PM ET

Size

6.9 KB

Accession

0001567619-22-011218

Insider Transaction Report

Form 4
Period: 2022-05-16
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2022-05-16+11,13011,130 total
  • Award

    Stock Option (Right to buy Common Stock)

    2022-05-16+17,49017,490 total
    Exercise: $77.32From: 2023-05-16Exp: 2032-05-15Common Stock (17,490 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on May 16, 2022. Price not applicable.
  • [F2]Option grant vests 12/48th on May 16, 2023 and 1/48th on the 16th day of each month thereafter.

Documents

1 file

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001927648

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 8:42 PM ET
Size
6.9 KB